AstraZeneca received approval from the FDA for Seroquel XR Extended-Release Tablets, a once-daily medicine for the treatment of schizophrenia in adult patients. The Seroquel XR development program was based on the need for a wider choice of medicines that offer convenient once-daily dosing. Schizophrenia is a serious brain disorder with symptoms including distorted perceptions of reality, hallucinations and delusions, illogical thinking, and flat or blunted emotions, and affects more than...